Clinical trials
Active, not recruiting Phase 3 trials in Latvia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 6 |
| 2019 | 7 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 7 |
| 2023 | 10 |
| 2024 | 8 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 54 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 8 |
| Merck Sharp & Dohme LLC | 6 |
| Novartis Pharmaceuticals | 6 |
| Hoffmann-La Roche | 5 |
| Janssen Research & Development, LLC | 3 |
| Novo Nordisk A/S | 3 |
| Eli Lilly and Company | 2 |
| Longboard Pharmaceuticals | 2 |
| UroGen Pharma Ltd. | 2 |
| Alnylam Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 6 |
| Colitis, Ulcerative | 6 |
| Arthritis, Psoriatic | 3 |
| Crohn Disease | 3 |
| Multiple Sclerosis | 3 |
| Urinary Bladder Neoplasms | 3 |
| Atherosclerosis | 2 |
| Carcinoma, Transitional Cell | 2 |
| Dyslipidemias | 2 |
| Epilepsy | 2 |
Trials
Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.